CALA - Calithera Biosciences, Inc.

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Currency in USD

Valuation Measures

Market Cap (intraday) 5220.48M
Enterprise Value 381.06M
Trailing P/E N/A
Forward P/E 1-2.59
PEG Ratio (5 yr expected) 1-0.03
Price/Sales (ttm)
Price/Book (mrq)1.58
Enterprise Value/Revenue 3N/A
Enterprise Value/EBITDA 6-0.92

Trading Information

Stock Price History

Beta (3Y Monthly) 1.46
52-Week Change 3-11.79%
S&P500 52-Week Change 33.55%
52 Week High 36.9000
52 Week Low 33.4300
50-Day Moving Average 33.9950
200-Day Moving Average 35.1330

Share Statistics

Avg Vol (3 month) 3476.31k
Avg Vol (10 day) 3284.62k
Shares Outstanding 553.77M
Float 46.36M
% Held by Insiders 11.31%
% Held by Institutions 167.90%
Shares Short (Aug 15, 2019) 41.18M
Short Ratio (Aug 15, 2019) 43.85
Short % of Float (Aug 15, 2019) 43.45%
Short % of Shares Outstanding (Aug 15, 2019) 42.19%
Shares Short (prior month Jul 15, 2019) 41.08M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 3N/A
Trailing Annual Dividend Yield 3N/A
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor (new per old) 248/1
Last Split Date 3Sep 19, 2014

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2018
Most Recent Quarter (mrq)Jun 30, 2019


Profit Margin 0.00%
Operating Margin (ttm)0.00%

Management Effectiveness

Return on Assets (ttm)-34.21%
Return on Equity (ttm)-60.16%

Income Statement

Revenue (ttm)N/A
Revenue Per Share (ttm)0.00
Quarterly Revenue Growth (yoy)N/A
Gross Profit (ttm)-43.94M
EBITDA -88.54M
Net Income Avi to Common (ttm)-86.19M
Diluted EPS (ttm)-2.2250
Quarterly Earnings Growth (yoy)N/A

Balance Sheet

Total Cash (mrq)153.21M
Total Cash Per Share (mrq)2.85
Total Debt (mrq)8.95M
Total Debt/Equity (mrq)6.42
Current Ratio (mrq)8.06
Book Value Per Share (mrq)2.59

Cash Flow Statement

Operating Cash Flow (ttm)-71.12M
Levered Free Cash Flow (ttm)-40.03M